|
A novel antibody drug conjugate to treat pancreatic cancer
Novel Antibody Conjugate to Treat Pancreatic Cancer
Background
Pancreatic cancer (PC) represents 7% of all cancer mortalities and has a strikingly poor prognosis with PC patients having a 5-year survival rate of less than 8% despite recently intensified studies of immunotherapy and nanomedicine therapy. The immunosuppressive microenvironment of pancreatic...
Published: 6/26/2025
|
Updated: 6/9/2023
|
Inventor(s): Marsha Moses, Jing Huang, Peng Guo
Keywords(s): Common, Oncology, Therapeutic
Category(s): Technology Classifications > Invention Type, Technology Classifications > Invention Type > Therapeutics, Technology Classifications > Disease Area, Technology Classifications > Disease Area > Oncology, Technology Classifications > Invention Type > Therapeutics > Large Molecule
|
